ArticleBioinformatics (Oxford, England)2025
Charting the structure-sequence landscape of light chain amyloids.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivationLight chain amyloidosis is a disease where misfolded antibody light chains (LCs) form toxic amyloid fibrils, leading to organ damage. Although LC overproduction occurs in all cases, only certain individuals develop the disease, suggesting that specific LC sequences and properties drive amyloid formation. This process is complex, involving both protein sequence and environmental factors, but mutations that destabilize the LC fold are linked to amyloid aggregation. Despite the significance of the disease, our understanding of LC fibril formation remains limited due to the lack of extensive data and technical challenges in studying amyloid structures. To address this, a tool is needed to compare unknown LC sequences with known structures and predict which amyloids are likely to adopt new conformations, guiding experimental investigations.
resultsHMMSTUFF addresses this by using a Hidden Markov Model to generate similarity scores between LC sequences and existing PDB templates, eventually modeling the LC amyloid structures similar enough to known templates. HMMSTUFF on one side expands our understanding of LC amyloid fibril conformations, and on the other highlights the gaps in our current knowledge of LC structural space. AVAILABILITY AND IMPLEMENTATION: HMMSTUFF is available as pypi package and as source code at https://github.com/grogdrinker/hmmstuff.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.